CHS Dream of a Cure Research Program – Research Grants
CHS Dream of a Cure Research Grants fund basic research to advance understanding, treatment, and cures for inherited bleeding disorders such as hemophilia and von Willebrand disease.
Funder: Canadian Hemophilia Society
Due Dates: November 28, 2025 | November 28, 2026 (annual deadline)
Funding Amounts: Up to $75,000/year per project; maximum $150,000 total over 2–3 years.
Summary: Supports basic scientific research to improve health, quality of life, and pursue cures for inherited bleeding disorders.
Description
The CHS Dream of a Cure Research Grants, funded by the Canadian Hemophilia Society and the Hemophilia Research Million Dollar Club, support basic scientific research aimed at improving the health and quality of life of individuals with inherited bleeding disorders, and advancing toward a cure. The program focuses on research relevant to hemophilia A and B, von Willebrand disease, rare factor deficiencies, platelet function disorders, and other congenital or acquired bleeding disorders. Successful proposals are expected to contribute to understanding, treatment, and eventual eradication of these conditions. Awardees must provide lay summaries and final reports suitable for broad dissemination.
